Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1352 of 5804
-
Nasal drops show promise for restoring vision in Brain-Injured children
Disease control CompletedThe goal of this observational study is to learn about the effects of nazally applied exosome treatment on visual functions in children with Phase 1 Cerebral visual impairment (CVİ). The main question it aims to answer is: Does exosome therapy administered via the nasal route f…
Sponsor: Hatice Semrin Timlioglu İper • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New injection could stop pancreatitis from turning deadly
Disease control Recruiting nowThe goal of this clinical trial is to test the safety and effectiveness of a single dose of RABI-767 given by endoscopic ultrasound (EUS) guided peripancreatic injection in participants with predicted severe acute pancreatitis. The main question the study aims to answer is: • I…
Phase: PHASE2 • Sponsor: Panafina, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Freezing heart tissue to stop AFib: new device under study
Disease control CompletedTo collect clinical data on safety, effectiveness and procedural success of Boston Scientific's Cardiac Cryoablation System (includes all BSC commercially available POLARx/POLARx Fit catheters) when used to perform pulmonary vein isolation (PVI) in the ablation treatment of de no…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a Mother's scent soothe preemies on ventilators? new study tests gentle comfort methods
Symptom relief OngoingIt will be done to shorten the hospital stay of the newborn and increase the quality of care by proving the positive effect of the safe wrapping method and the smell of breast milk on the physiological parameters and stress level of the newborn in premature newborns receiving mec…
Phase: NA • Sponsor: KTO Karatay University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New drug cocktail aims to tackle rare lymphoma
Disease control Recruiting nowThis is a multi-center, prospective cohort study. The main purpose of Cohort A is to evaluate the efficacy and safety of Orelabrutinib combined with BR (bendamustine and rituximab) for previously untreated young patients with MZL; the purpose of Cohort B is to assess the efficacy…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New balloon treatment could unclog tiny heart arteries without stents
Disease control ENROLLING_BY_INVITATIONThe GENOSS PCB-De Novo study aims to evaluate the long-term efficacy and safety of a paclitaxel-coated balloon catheter containing shellac and vitamin E excipients (Genoss® DCB) in patients with De novo small coronary artery disease.
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 13:26 UTC
-
IPad game aims to train young brains to fight OCD
Symptom relief Recruiting nowThis study aims to examine the effects of a game-like program called cognitive control training (CT) for children with obsessive compulsive disorder (OCD). Children enrolled in this study will receive 4 weeks of the at-home computerized cognitive training program (AKL-T01) delive…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Engineered immune cells take on Hard-to-Treat breast cancer
Disease control Recruiting nowThis phase 1, single-center, open-label study explores the safety of escalating doses of chimeric antigen receptor T cells (CAR-T) cells in subjects with relapsed/refractory triple-negative breast cancer (TNBC).
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could skipping radiation to the tongue reduce side effects without raising cancer risk?
Disease control Recruiting nowThis study will test whether limiting standard photon intensity modulated radiation therapy (IMRT) to exclude the oral tongue surgical site can decrease the risk of side effects caused by oral radiation. The researchers will also find out if this approach affects the rate of dise…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug BL-B16D1 enters early human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis study is an open, multicenter, increasing dose and dose extension nonrandomized phase I clinical study to evaluate the safety, tolerance, pharmacokinetic characteristics and preliminary effectiveness of BL-B16D1 in recurrent or metastatic head and neck squamous cell carcinom…
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:46 UTC
-
Could a lung drug stop pancreatitis Flare-Ups?
Disease control Recruiting nowThis clinical will evaluate the safety, tolerability and early efficacy of pirenidone in patients with recurrent acute pancreatitis.
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New pill takes on KRAS-Mutant cancers in early trial
Disease control OngoingThe purpose of this study is to learn about the safety and effects of the study medicine alone or when given together with other anti-cancer therapies. This study also aims to find the best dose. This study is seeking participants who have solid tumors (a mass of abnormal cells …
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
5 sessions instead of 40: new prostate cancer radiation trial launches
Disease control Recruiting nowTo look at the safety and effectiveness of stereotactic body radiation therapy (SBRT) in treating advanced or high-risk prostate cancer.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Universal flu vaccine enters first human trial
⭐️ VACCINE ⭐️ CompletedThis study is a single center, randomized, double-blind, placebo-controlled, dose-finding, FIH, Phase 1 study to assess the safety, tolerability, and immunogenicity of the adjuvanted Universal Influenza Vaccine (fH1/DSP-0546LP) after IM administrations in healthy adults.
Phase: PHASE1 • Sponsor: Sumitomo Pharma Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:09 UTC
-
AI and poop analysis could revolutionize colon cancer screening
Diagnosis Recruiting nowColorectal cancer (CRC) is the second most common type of cancer worldwide. The European Union recommends national CRC screening for people aged between 50 and 74. Generally, an immunological test called FIT (Fecal Immunochemical Test), based on the quantitative detection of huma…
Sponsor: Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement • Aim: Diagnosis
Last updated Jun 26, 2026 17:39 UTC
-
Stitch and hormone combo may stop preterm birth
Prevention Recruiting nowThis study compares the effectiveness of cervical cerclage with vaginal progesterone to vaginal progesterone only for the prevention of preterm birth in women with a singleton pregnancy and a short cervical length. Participants will be randomly assigned in a 1:1 ratio to receive …
Phase: NA • Sponsor: Mỹ Đức Hospital • Aim: Prevention
Last updated Jun 26, 2026 18:16 UTC
-
Digital Check-In could ease cancer treatment side effects
Symptom relief Recruiting nowThe PI and the research team developed the New York University (NYU) Electronic Patient Visit Assessment (ePVA) for head and neck cancer (HNC) as a patient-reported outcome measure (PRO) for the early detection of uncontrolled symptoms. The ePVA is digital patient-reported sympto…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Robotic lung biopsy: a sharper tool for spotting cancer?
Diagnosis OngoingThis randomized controlled trial evaluates the integration of cone-beam computed tomography (CBCT) and robotic-assisted bronchoscopy (RAB) for diagnosing pulmonary lesions, hypothesizing improved diagnostic yield compared to traditional methods. The trial involves 2 study arms (2…
Phase: NA • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Personalized preventive care aims to cut deaths by 20% in low-income communities
Disease control OngoingThe purpose of this research study is to investigate if a personalized intervention including parts such as navigation (focus on patient outreach efforts, missed and completed encounters), personalization (individual health benefits) and compensation (value health-related costs b…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New Antibody-Drug conjugate takes aim at tough leukemias
Disease control OngoingThis is the first-in-human trial with BYON4413 to evaluate safety, PK, immunogenicity, and anti-leukemia activity of BYON4413 in patients with AML or MDS.
Phase: PHASE1 • Sponsor: Byondis B.V. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC